A recent study reveals that patients who come off new slimming jabs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who stop traditional diet and exercise regimens.
Research printed in a leading medical journal demonstrates that while obese individuals can lose about a fifth of their total mass while on the medication, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Individuals using these medications need to be cognizant of the danger of rapid rebound weight gain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment mass within about 18 months.
Analyzing Therapies
The analysis, which reviewed 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists note that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Regain
Doctors suggest the way of the injections is key to understanding the accelerated rebound.
These medications mimic a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of the hormone levels far above than the body's typical production may cause the body to produce less of its own natural hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this medication means hunger is uncontrolled, making overeating a significant risk."
A Lifelong Issue?
The NHS recommend the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, due to the likelihood of relapse, the treatment is often ongoing.
This perspective is supported by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," akin to managing diseases like hypertension.
User Accounts
People who have stopped the medication report a powerful resurgence of appetite.
"It was like a trigger flipping and you're instantly starving," said an individual.
The struggle is compounded if users have not adopted sustainable lifestyle or habit modifications during therapy.
Significant Interest
Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with demand being substantial.
- Use is more common among women than men.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while the jabs are potent agents for shedding pounds, they are not a magic cure and maintained weight loss likely depends on integrated behavioural support.
